The in vivo inhibitory effects of HDFs with high expression of ATF3 on melanoma formation and growth suggests a potential new approach for treatment of melanoma in the clinic, namely inducing tumor stromal cells to increase ATF3 expression. This evidence concerns the gene ATF3 and melanoma.